nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achieving an Early Myeloma Response in Patients With Kidney Impairment
|
Stringer, Stephanie |
|
2012 |
19 |
5 |
p. 303-311 9 p. |
artikel |
2 |
Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients
|
Leung, Nelson |
|
2012 |
19 |
5 |
p. 297-302 6 p. |
artikel |
3 |
Editorial Board
|
|
|
2012 |
19 |
5 |
p. A1- 1 p. |
artikel |
4 |
Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective
|
Kastritis, Esftathios |
|
2012 |
19 |
5 |
p. 312-323 12 p. |
artikel |
5 |
Evolving Strategies in the Diagnosis, Treatment, and Monitoring of Myeloma Kidney
|
Hutchison, Colin |
|
2012 |
19 |
5 |
p. 279-281 3 p. |
artikel |
6 |
Masthead
|
|
|
2012 |
19 |
5 |
p. IFC- 1 p. |
artikel |
7 |
Monoclonal Gammopathies: Disambiguation
|
Yee, Jerry |
|
2012 |
19 |
5 |
p. 277-278 2 p. |
artikel |
8 |
Monoclonal Gammopathy of Undetermined Significance: An Update for Nephrologists
|
Parry, H.M. |
|
2012 |
19 |
5 |
p. 291-296 6 p. |
artikel |
9 |
Myeloma Kidney: Improving Clinical Outcomes?
|
Haynes, Richard |
|
2012 |
19 |
5 |
p. 342-351 10 p. |
artikel |
10 |
Optimizing Treatment Strategies in Myeloma Cast Nephropathy: Rationale for a Randomized Prospective Trial
|
Bridoux, Frank |
|
2012 |
19 |
5 |
p. 333-341 9 p. |
artikel |
11 |
Table of Contents
|
|
|
2012 |
19 |
5 |
p. A3-A4 nvt p. |
artikel |
12 |
The Pathogenesis of Acute Kidney Impairment in Patients With Multiple Myeloma
|
Batuman, Vecihi |
|
2012 |
19 |
5 |
p. 282-286 5 p. |
artikel |
13 |
The Rationale and Evidence Base for the Direct Removal of Serum-Free Light Chains in the Management of Myeloma Kidney
|
Cockwell, Paul |
|
2012 |
19 |
5 |
p. 324-332 9 p. |
artikel |
14 |
The Role of Immunological Assessment in Patients With Acute Kidney Injury and Possible Myeloma
|
Lachmann, Helen J. |
|
2012 |
19 |
5 |
p. 287-290 4 p. |
artikel |